Nov 1, 2004: David Anderson joined the Company as President and CEO in November 2004. Mr. Anderson joins Gentis from Sterilox Technologies, Inc., a high technology disinfection company that he had led since 2000. In the five years that Mr. Anderson was CEO at Sterilox, he grew sales from less than $400,000 to almost $20 million and successfully obtained FDA approvals for three products and EPA approvals for several more. Prior to Sterilox, Mr. Anderson was the CEO of Bionx Implants, a high technology developer and manufacturer of resorbable orthopaedic devices. During his tenure at Bionx, Mr. Anderson lead the efforts that resulted in FDA clearances for over 60 products and sales growth from zero to over $20 million. Mr. Anderson also successfully raised $15 million in venture funding for Bionx and led its IPO in 1997.
Mr. Anderson has also served as: CEO of Kensey Nash (Advanced technology in Cardiology); a venture capitalist who constructed the early basis for Integra LifeSciences and a founder of Osteotech, one of the first high technology orthopaedic companies. Mr. Anderson began his healthcare career with Schering Plough after graduating from Cornell with a B.S. in Chemical Engineering.